Medications for Atrial Fibrillation

6 results
  • eliquis - apixaban tablet, film coated

    (Apixaban)
    E.R. Squibb & Sons, L.L.C.
    Eliquis is a factor Xa inhibitor used in adults to reduce stroke risk in nonvalvular atrial fibrillation, prevent DVT after hip/knee surgery, and treat/prevent recurrent DVT and PE. Also indicated for VTE treatment and recurrence reduction in pediatric patients after initial anticoagulation.
  • multaq - dronedarone tablet, film coated

    (Dronedarone)
    Sanofi-Aventis U.S. Llc
    MULTAQ reduces the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation.
  • pradaxa - dabigatran etexilate mesylate capsule

    (Dabigatran Etexilate Mesylate)
    Boehringer Ingelheim Pharmaceuticals Inc.
    Pradaxa is a direct thrombin inhibitor used to reduce stroke and embolism risk in adults with non-valvular atrial fibrillation, treat and prevent recurrence of DVT and pulmonary embolism in adults, prevent DVT/PE after hip replacement, and treat or prevent VTE recurrence in patients aged 8–17.
  • sotylize - sotalol hydrochloride solution

    (Sotalol Hydrochloride)
    Azurity Pharmaceuticals, Inc.
    SOTYLIZE is an antiarrhythmic used to treat life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and to maintain normal sinus rhythm in adults with highly symptomatic atrial fibrillation or atrial flutter currently in sinus rhythm.
  • xarelto - rivaroxaban tablet, film coated

    (Rivaroxaban)
    Janssen Pharmaceuticals, Inc.
    Xarelto is a factor Xa inhibitor that reduces stroke risk in atrial fibrillation, treats and prevents DVT and pulmonary embolism, lowers cardiovascular risk in CAD and PAD (with aspirin), and provides VTE prophylaxis after joint replacement surgery, in hospitalized medical patients, and in pediatric patients.